Our Focus
Therapeutic Areas
We aim to build an efficient engine for small molecule innovation and a research pipeline for cancer and autoimmune diseases, providing global patients with safer, more effective, and more accessible treatment options.
Cancer has become one of the leading causes of death and a major healthcare burden. We focus on the molecular mechanisms of carcinogenesis and the characteristics of tumor microenvironment, and are committed to discovering drugs that can help to regulate the expression of oncogenes and their signaling pathways, disrupt the tumor microenvironment, and restore immune normalcy.
Autoimmune diseases manifest as the immune system of patients become overactive or dysregulated, leading to attacks and damage to own tissues. Coherent with our discovery efforts in immuno-oncology, we work closely with medical professionals to engage untapped mechanisms for hard to treat immunological disorders.